Blood test could unlock hidden clues to dialysis quality
NCT ID NCT07713680
First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time
Summary
This study looks at how a protein called β2-microglobulin builds up in people with kidney failure and how it changes during and after dialysis. Researchers will take blood samples from 30 dialysis patients at multiple time points to track the protein's levels. The goal is to create a model that predicts the final, stable level of this protein after dialysis, which could become a new way to measure how well dialysis is working.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test that helps doctors better assess how well dialysis removes waste proteins, potentially improving long-term outcomes for kidney patients.
- What could go wrong
- This is a small, early-stage observational study with only 30 participants, so the predictive model may not be accurate for all dialysis patients. It does not test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL DISEASE, END STAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
East and North Hertfordshire NHS Trust
RECRUITINGStevenage, SG1 4AB, United Kingdom
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.